These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 24491452)

  • 1. Value of antimüllerian hormone as a prognostic indicator of in vitro fertilization outcome.
    Reichman DE; Goldschlag D; Rosenwaks Z
    Fertil Steril; 2014 Apr; 101(4):1012-8.e1. PubMed ID: 24491452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does the time interval between antimüllerian hormone serum sampling and initiation of ovarian stimulation affect its predictive ability in in vitro fertilization-intracytoplasmic sperm injection cycles with a gonadotropin-releasing hormone antagonist? A retrospective single-center study.
    Polyzos NP; Nelson SM; Stoop D; Nwoye M; Humaidan P; Anckaert E; Devroey P; Tournaye H
    Fertil Steril; 2013 Aug; 100(2):438-44. PubMed ID: 23602319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimüllerian hormone levels are strongly associated with live-birth rates after assisted reproduction.
    Brodin T; Hadziosmanovic N; Berglund L; Olovsson M; Holte J
    J Clin Endocrinol Metab; 2013 Mar; 98(3):1107-14. PubMed ID: 23408576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients.
    Arce JC; La Marca A; Mirner Klein B; Nyboe Andersen A; Fleming R
    Fertil Steril; 2013 May; 99(6):1644-53. PubMed ID: 23394782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum antimüllerian hormone levels are independently related to miscarriage rates after in vitro fertilization-embryo transfer.
    Tarasconi B; Tadros T; Ayoubi JM; Belloc S; de Ziegler D; Fanchin R
    Fertil Steril; 2017 Sep; 108(3):518-524. PubMed ID: 28865551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic indicators of assisted reproduction technology outcomes of cycles with ultralow serum antimüllerian hormone: a multivariate analysis of over 5,000 autologous cycles from the Society for Assisted Reproductive Technology Clinic Outcome Reporting System database for 2012-2013.
    Seifer DB; Tal O; Wantman E; Edul P; Baker VL
    Fertil Steril; 2016 Feb; 105(2):385-93.e3. PubMed ID: 26515380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian response prediction in controlled ovarian stimulation for IVF using anti-Müllerian hormone in Chinese women: A retrospective cohort study.
    Zheng H; Chen S; Du H; Ling J; Wu Y; Liu H; Liu J
    Medicine (Baltimore); 2017 Mar; 96(13):e6495. PubMed ID: 28353597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Live birth from a 46-year-old using fresh autologous oocytes through in vitro fertilization.
    Trolice MP
    Fertil Steril; 2014 Jul; 102(1):96-8. PubMed ID: 24796763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol.
    Hazout A; Bouchard P; Seifer DB; Aussage P; Junca AM; Cohen-Bacrie P
    Fertil Steril; 2004 Nov; 82(5):1323-9. PubMed ID: 15533354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimüllerian hormone: prediction of cumulative live birth in gonadotropin-releasing hormone antagonist treatment for in vitro fertilization.
    Hamdine O; Eijkemans MJC; Lentjes EGW; Torrance HL; Macklon NS; Fauser BCJM; Broekmans FJ
    Fertil Steril; 2015 Oct; 104(4):891-898.e2. PubMed ID: 26196233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
    Nardo LG; Gelbaya TA; Wilkinson H; Roberts SA; Yates A; Pemberton P; Laing I
    Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of ovarian reserve parameters for predicting live births in women undergoing in vitro fertilization.
    Lukaszuk K; Kunicki M; Liss J; Lukaszuk M; Jakiel G
    Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):173-7. PubMed ID: 23485092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of in-cycle antimüllerian hormone levels to predict cycle outcome.
    Blazar AS; Lambert-Messerlian G; Hackett R; Krotz S; Carson SA; Robins JC
    Am J Obstet Gynecol; 2011 Sep; 205(3):223.e1-5. PubMed ID: 21636068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic antimüllerian hormone levels during controlled ovarian hyperstimulation predict in vitro fertilization response and pregnancy outcomes.
    Styer AK; Gaskins AJ; Brady PC; Sluss PM; Chavarro JE; Hauser RB; Toth TL
    Fertil Steril; 2015 Nov; 104(5):1153-61.e1-7. PubMed ID: 26315051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of antimüllerian hormone assays on the outcomes of in vitro fertilization: a prospective controlled study.
    Aboulghar M; Saber W; Amin Y; Aboulghar MM; Serour G; Mansour R
    Fertil Steril; 2014 Jan; 101(1):134-7. PubMed ID: 24268704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of antral follicle count and serum anti-Müllerian hormone: Which is better for live birth prediction in patients aged over 40 with their first IVF treatment?
    Lee Y; Kim TH; Park JK; Eum JH; Lee HJ; Kim J; Lyu SW; Kim YS; Lee WS; Yoon TK
    Eur J Obstet Gynecol Reprod Biol; 2018 Feb; 221():151-155. PubMed ID: 29306180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of anti-Müllerian hormone and antral follicle count to predict the potential of oocytes and embryos.
    Majumder K; Gelbaya TA; Laing I; Nardo LG
    Eur J Obstet Gynecol Reprod Biol; 2010 Jun; 150(2):166-70. PubMed ID: 20223579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimüllerian hormone as predictor of implantation and clinical pregnancy after assisted conception: a systematic review and meta-analysis.
    Tal R; Tal O; Seifer BJ; Seifer DB
    Fertil Steril; 2015 Jan; 103(1):119-30.e3. PubMed ID: 25450298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can highly sensitive antimüllerian hormone testing predict failed response to ovarian stimulation?
    Burks HR; Ross L; Opper N; Paulson E; Stanczyk FZ; Chung K
    Fertil Steril; 2015 Sep; 104(3):643-8. PubMed ID: 26158904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of women with elevated antimüllerian hormone levels (AMH): correlation of AMH with polycystic ovarian syndrome phenotypes and assisted reproductive technology outcomes.
    Tal R; Seifer DB; Khanimov M; Malter HE; Grazi RV; Leader B
    Am J Obstet Gynecol; 2014 Jul; 211(1):59.e1-8. PubMed ID: 24593938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.